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Background
It is known that type 1 angiotensin II (Ang II) receptor
(AGTR1) could be related with the pathogenesis of bron-
chial asthma. It is involved in Th polarization, through
different signaling pathways modulating allergic airway
inflammation, and also may participate in airway remodel-
ing and bronchoconstriction, that could be related with
AGTR1 polymorphism. The purpose of this study is to
analyze the association between AGTR1 1166A/C (rs5186)
gene polymorphism with asthma severity.
Methods
Asthmatic patients : n=37; were compared with a control
group of n=32 healthy blood donors. The AGTR1 1166A/C
(rs5186) gene polymorphism was determined by PCR-RFLP
(polymerase chain reaction- restriction fragment length
polymorphism). Control of asthma assessed by validated
instrument (ACQ7 and PAQLQ). Statistical analysis was
performed with PASW version 18 establishing a signifi-
cance level of p<0.05.
Results
The mean age of the 37 asthmatics was 40 ± 18 years;
minimum 7 and maximum 71; 24 females and 13 males;
35 Caucasians and 2 non-Caucasians; 34 atopics and 3
non-atopics; 22 with controlled and 15 with uncontrolled
asthma. The control group for this polymorphism is in
Hardy-Weinberg equilibrium (p>0.05). In asthmatics the
frequencies of the allele A is 53% and the allele C is 47%;
in controls: 64% and 36% respectively. There is no statis-
tical difference between these groups (p>0.05). Genotypes
in the asthmatics- AA: 29.7%; AC: 46%; CC: 24.3%; in
control group- AA: 34.4%; AC: 59.4%; CC: 6.2%. There is
no statistical difference between these groups (p>0.05).
When we associate AGTR1 genotypes, there was a
tendency, but not significant, between asthmatics and
controls (CC vs AC+AA; p=0.086) being CC genotype
more frequent in the asthma-group. In asthmatics, there
is no statistical difference (p>0.05) in genotypes: between
atopics and non atopics; controlled and uncontrolled
asthma; males and females; by ethnic-group; and in the
different age-groups.
Conclusions
Our findings provided some evidence that there is a trend,
although not significant, that AGTR1 gene A1166C poly-
morphism might be a genetic marker for the pathophysiol-
ogy of allergic airway inflammation, remodeling and
bronchoconstriction in asthmatic disease.
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